News
Fintel on MSN12h
B. Riley Securities Initiates Coverage of Capricor Therapeutics (CAPR) with Buy RecommendationFintel reports that on June 26, 2025, B. Riley Securities initiated coverage of Capricor Therapeutics (NasdaqCM:CAPR) with a ...
Capricor Therapeutics updates on Deramiocel BLA for duchenne muscular dystrophy: San Diego Thursday, June 26, 2025, 15:30 Hrs [IST] Capricor Therapeutics, a biotechnology company ...
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback